Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Breast cancer expression of DAP12 is associated with skeletal and liver metastases and poor survival.

Shabo I, Olsson H, Stål O, Svanvik J.

Clin Breast Cancer. 2013 Oct;13(5):371-7. doi: 10.1016/j.clbc.2013.05.003. Epub 2013 Jun 27.

PMID:
23810293
2.

The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.

Medrek C, Pontén F, Jirström K, Leandersson K.

BMC Cancer. 2012 Jul 23;12:306. doi: 10.1186/1471-2407-12-306.

3.

Expression of macrophage antigens by tumor cells.

Shabo I, Svanvik J.

Adv Exp Med Biol. 2011;714:141-50. doi: 10.1007/978-94-007-0782-5_7. Review.

PMID:
21506012
4.

Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival.

Shabo I, Stål O, Olsson H, Doré S, Svanvik J.

Int J Cancer. 2008 Aug 15;123(4):780-6. doi: 10.1002/ijc.23527.

5.

Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time.

Shabo I, Olsson H, Sun XF, Svanvik J.

Int J Cancer. 2009 Oct 15;125(8):1826-31. doi: 10.1002/ijc.24506.

6.

Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells.

Bakker AB, Baker E, Sutherland GR, Phillips JH, Lanier LL.

Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9792-6.

7.

Macrophage traits in cancer cells are induced by macrophage-cancer cell fusion and cannot be explained by cellular interaction.

Shabo I, Midtbö K, Andersson H, Åkerlund E, Olsson H, Wegman P, Gunnarsson C, Lindström A.

BMC Cancer. 2015 Nov 20;15:922. doi: 10.1186/s12885-015-1935-0.

8.

The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.

Kong LQ, Zhu XD, Xu HX, Zhang JB, Lu L, Wang WQ, Zhang QB, Wu WZ, Wang L, Fan J, Tang ZY, Sun HC.

PLoS One. 2013;8(3):e59771. doi: 10.1371/journal.pone.0059771. Epub 2013 Mar 29.

9.

[Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].

Wojtacki J, Kruszewski WJ, Sliwińska M, Kruszewska E, Hajdukiewicz W, Sliwiński W, Rolka-Stempniewicz G, Góralczyk M, Leśniewski-Kmak K.

Przegl Lek. 2001;58(6):498-503. Polish.

PMID:
11816740
10.

Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.

Lan C, Huang X, Lin S, Huang H, Cai Q, Wan T, Lu J, Liu J.

Technol Cancer Res Treat. 2013 Jun;12(3):259-67. doi: 10.7785/tcrt.2012.500312. Epub 2012 Dec 26.

PMID:
23289476
11.

Distant metastasis in triple-negative breast cancer.

Tseng LM, Hsu NC, Chen SC, Lu YS, Lin CH, Chang DY, Li H, Lin YC, Chang HK, Chao TC, Ouyang F, Hou MF.

Neoplasma. 2013;60(3):290-4. doi: 10.4149/neo_2013_038.

PMID:
23373998
12.

Tumor associated macrophage × cancer cell hybrids may acquire cancer stem cell properties in breast cancer.

Ding J, Jin W, Chen C, Shao Z, Wu J.

PLoS One. 2012;7(7):e41942. doi: 10.1371/journal.pone.0041942. Epub 2012 Jul 25.

13.

Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis.

Joyce-Shaikh B, Bigler ME, Chao CC, Murphy EE, Blumenschein WM, Adamopoulos IE, Heyworth PG, Antonenko S, Bowman EP, McClanahan TK, Phillips JH, Cua DJ.

J Exp Med. 2010 Mar 15;207(3):579-89. doi: 10.1084/jem.20090516. Epub 2010 Mar 8.

14.

Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome.

Carus A, Ladekarl M, Hager H, Pilegaard H, Nielsen PS, Donskov F.

Lung Cancer. 2013 Jul;81(1):130-7. doi: 10.1016/j.lungcan.2013.03.003. Epub 2013 Mar 26.

PMID:
23540719
15.

Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.

Maniecki MB, Etzerodt A, Ulhøi BP, Steiniche T, Borre M, Dyrskjøt L, Orntoft TF, Moestrup SK, Møller HJ.

Int J Cancer. 2012 Nov 15;131(10):2320-31. doi: 10.1002/ijc.27506. Epub 2012 Mar 28.

16.

Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.

Kim ST, Jeong H, Woo OH, Seo JH, Kim A, Lee ES, Shin SW, Kim YH, Kim JS, Park KH.

Am J Clin Oncol. 2013 Jun;36(3):224-31. doi: 10.1097/COC.0b013e3182467d90.

PMID:
22495453
17.

Disparities in the survival improvement of recurrent breast cancer.

Anan K, Mitsuyama S, Koga K, Tanabe R, Saimura M, Tanabe Y, Watanabe M, Suehara N, Matsunaga H, Nishihara K, Abe Y, Nakano T, Tamae K, Ono M, Toyoshima S.

Breast Cancer. 2010;17(1):48-55. doi: 10.1007/s12282-009-0103-2. Epub 2009 Apr 7.

PMID:
19350357
18.

Morphometric analysis of liver macrophages in patients with colorectal liver metastasis.

Miyagawa S, Miwa S, Soeda J, Kobayashi A, Kawasaki S.

Clin Exp Metastasis. 2002;19(2):119-25.

PMID:
11964075
19.

The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time.

Ma J, Liu L, Che G, Yu N, Dai F, You Z.

BMC Cancer. 2010 Mar 25;10:112. doi: 10.1186/1471-2407-10-112.

20.

Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.

Kamper P, Bendix K, Hamilton-Dutoit S, Honoré B, Nyengaard JR, d'Amore F.

Haematologica. 2011 Feb;96(2):269-76. doi: 10.3324/haematol.2010.031542. Epub 2010 Nov 11.

Supplemental Content

Support Center